Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 2
1999 1
2000 1
2001 2
2002 1
2003 1
2004 2
2005 1
2006 4
2007 1
2008 2
2010 2
2011 1
2012 3
2014 1
2015 2
2016 1
2017 1
2018 2
2021 1
2022 5
2023 8
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
Natalizumab continuation versus switching to ocrelizumab after PML risk stratification in RRMS patients: a natural experiment.
Muñoz-Vendrell A, Arroyo-Pereiro P, León I, Bau L, Matas E, Martínez-Yélamos A, Martínez-Yélamos S, Romero-Pinel L. Muñoz-Vendrell A, et al. Among authors: martinez yelamos a. J Neurol. 2023 May;270(5):2559-2566. doi: 10.1007/s00415-023-11645-x. Epub 2023 Mar 13. J Neurol. 2023. PMID: 36913038 Free PMC article. Clinical Trial.
Direct health costs of amyotrophic lateral sclerosis in a multidisciplinary ALS unit in Catalonia (Spain).
Mora T, Domínguez R, Assialioui A, Paipa A, Moreno R, Corbella X, Martínez-Yelamos A, Povedano M. Mora T, et al. Among authors: martinez yelamos a. Amyotroph Lateral Scler Frontotemporal Degener. 2023 Feb;24(1-2):133-138. doi: 10.1080/21678421.2022.2080560. Epub 2022 Jun 7. Amyotroph Lateral Scler Frontotemporal Degener. 2023. PMID: 35670332 Review.
Baseline serum neurofilament light chain levels differentiate aggressive from benign forms of relapsing-remitting multiple sclerosis: a 20-year follow-up cohort.
Arroyo Pereiro P, Muñoz-Vendrell A, León Moreno I, Bau L, Matas E, Romero-Pinel L, Martínez Yélamos A, Martínez Yélamos S, Andrés-Benito P. Arroyo Pereiro P, et al. Among authors: martinez yelamos a. J Neurol. 2024 Apr;271(4):1599-1609. doi: 10.1007/s00415-023-12135-w. Epub 2023 Dec 12. J Neurol. 2024. PMID: 38085343 Free PMC article.
Fingolimod-associated progressive multifocal leukoencephalopathy in a multiple sclerosis patient with a good response to filgrastim.
Lombardo-Del Toro P, Bragado-Trigo I, Arroyo P, Tena-Cucala R, Bau L, Matas E, Muñoz-Vendrell A, Simó M, Pons-Escoda A, Martínez-Yélamos A, Martínez-Yélamos S, Romero-Pinel L. Lombardo-Del Toro P, et al. Among authors: martinez yelamos a. J Neurol. 2023 Nov;270(11):5196-5200. doi: 10.1007/s00415-023-11865-1. Epub 2023 Jul 17. J Neurol. 2023. PMID: 37460853 No abstract available.
Kappa free light chains index in multiple sclerosis very long-term prognosis.
Arroyo-Pereiro P, García-Serrano L, Morandeira F, Urban B, Mas V, Framil M, León I, Muñoz-Vendrell A, Matas E, Romero-Pinel L, Martínez-Yélamos A, Martínez-Yélamos S, Bau L. Arroyo-Pereiro P, et al. Among authors: martinez yelamos a. Front Immunol. 2023 Oct 11;14:1223514. doi: 10.3389/fimmu.2023.1223514. eCollection 2023. Front Immunol. 2023. PMID: 37885887 Free PMC article.
The T1-dark-rim: A novel imaging sign for detecting smoldering inflammation in multiple sclerosis.
Naval-Baudin P, Pons-Escoda A, Castillo-Pinar A, Martínez-Zalacaín I, Arroyo-Pereiro P, Flores-Casaperalta S, Garay-Buitron F, Calvo N, Martinez-Yélamos A, Cos M, Martínez-Yélamos S, Majós C. Naval-Baudin P, et al. Among authors: martinez yelamos a. Eur J Radiol. 2024 Apr;173:111358. doi: 10.1016/j.ejrad.2024.111358. Epub 2024 Feb 5. Eur J Radiol. 2024. PMID: 38340569 Free article.
[Access to orphan drugs for the treatment of spinal muscular atrophy in Spain].
García-Parra B, Guiu JM, Modamio P, Martínez-Yélamos A, Mariño-Hernández EL, Povedano M. García-Parra B, et al. Among authors: martinez yelamos a. Rev Neurol. 2022 Nov 1;75(9):261-267. doi: 10.33588/rn.7509.2022298. Rev Neurol. 2022. PMID: 36285446 Free PMC article. Spanish.
42 results